Goeppert, Benjamin
Roessler, Stephanie
Renner, Marcus
Singer, Stephan
Mehrabi, Arianeb
Vogel, Monika Nadja
Pathil, Anita
Czink, Elena
Köhler, Bruno
Springfeld, Christoph
Pfeiffenberger, Jan
Rupp, Christian
Weiss, Karl Heinz
Schirmacher, Peter
von Knebel Doeberitz, Magnus
Kloor, Matthias
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB/TR 209, SFB/TR 209)
Article History
Received: 5 May 2018
Revised: 6 July 2018
Accepted: 6 July 2018
First Online: 31 October 2018
Competing interests
: The authors declare no competing interests.
: This study is an investigator-initiated trial and was carried out with the support of the German Research Foundation (DFG) SFB/TR 209 “Liver Cancer”.
: This study was performed in accordance with the Declaration of Helsinki. All patients provided written informed consent for the use of the samples, and the local Ethics Committee (Ethics Committee University of Heidelberg) approved the study (No. 206/2005).
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
: All data supporting the results reported in the article can be found in the Departments of General Pathology and Applied Tumor Biology of the Institute of Pathology, University Hospital Heidelberg.